当前位置: X-MOL 学术Dalton Trans. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Rhenium(I) and technetium(I) complexes with megazol derivatives: towards the development of a theranostic platform for Chagas disease
Dalton Transactions ( IF 3.5 ) Pub Date : 2024-11-06 , DOI: 10.1039/d4dt02714k
Ana C. R. Gonçalves, Silvia H. Libardi, Júlio C. Borges, Ronaldo J. Oliveira, Carla Gotzmann, Olivier Blacque, Sergio de Albuquerque, Carla D. Lopes, Roger Alberto, Pedro I. S. Maia

The diagnosis and treatment of Chagas disease (CD) in the chronic phase remains a challenge. With that in mind, a potential theranostic device based on the trypanocidal agent known as megazol and the fac-M(CO)3+ (M = Re or 99mTc) fragment is proposed in the present work. The peripheral structure of megazol (LH,H) was modified to obtain the compounds LR1,R2 (R1 = H, R2 = Me and R1 = R2 = Me), which were used in the syntheses of complexes of composition [ReBr(CO)3LR1,R2]. These compounds were studied by elemental analysis, FTIR, UV-vis, NMR (1H and 13C), HR-ESI-MS, HPLC/UPLC and single-crystal XRD. The trypanocidal activity of the rhenium complexes was evaluated in vitro against the intracellular form of Trypanosoma cruzi. With exception of the [ReBr(CO)3LMe,Me] complex, all compounds are more active than the standard drug, benznidazole (Bzn), while [ReBr(CO)3LH,H] also exhibited a much higher selectivity index. In addition, the interaction of megazol and its ReI complex was evaluated with the T. cruzi Old Yellow Enzyme (TcOYE) by both experimental and computational methods. The data showed that megazol as well as its metal complex exhibited a higher affinity for TcOYE compared to Bzn. Finally, the labelling of megazol with 99mTc was successfully carried out. However, the results indicated that the Re complexes used as standards were not homologous with the 99mTc complexes. Despite this discrepancy, this research suggests that the investigation into Re and 99mTc complexes with megazol could lead to the development of a theranostic device for CD in a near future.

中文翻译:


铼 (I) 和锝 (I) 配合物与兆唑衍生物:迈向美洲锥虫病治疗诊断学平台的开发



慢性期恰加斯病 (CD) 的诊断和治疗仍然是一个挑战。考虑到这一点,本研究提出了一种基于称为 megazol 的锥虫杀灭剂和 fac-M(CO)3+(M = Re 或 99mTc)片段的潜在治疗诊断装置。修饰 megazol (LH,H) 的外周结构以获得化合物 LR1,R2 (R1 = H, R2 = Me 和 R1 = R2 = Me),这些化合物用于合成组成物 [ReBr(CO)3LR1,R2] 的复合物。通过元素分析、FTIR、UV-vis、NMR(1H 和 13C)、HR-ESI-MS、HPLC/UPLC 和单晶 XRD 研究了这些化合物。在体外评估铼复合物的锥虫杀灭活性与细胞内形式的克氏锥虫。除 [ReBr(CO)3LMe,Me] 复合物外,所有化合物都比标准药物苄硝唑 (Bzn) 更具活性,而 [ReBr(CO)3LH,H] 也表现出高得多的选择性指数。此外,通过实验和计算方法评估了 megazol 及其 Re 复合物与 T. cruzi Old Yellow Enzyme (TcOYE) 的相互作用。数据显示,与 Bzn 相比,megazol 及其金属络合物对 TcOYE 表现出更高的亲和力。最后,成功进行了 99mTc 的 megazol 标记。然而,结果表明,用作标准的 Re 复合物与 99mTc 复合物不是同源的。 尽管存在这种差异,但这项研究表明,对 Re 和 99mTc 配合物与 megazol 的研究可能会导致在不久的将来开发用于 CD 的治疗诊断装置。
更新日期:2024-11-06
down
wechat
bug